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ABSTRACT
Leptospirosis is a worldwide zoonosis caused by pathogenic Leptospira spp. Although the currently 
available whole cell leptospiral vaccines can induce protection against Leptospirosis, further study for a new 
generation of vaccine that can stimulate long-term immunity is needed. Biodegradable microspheres as antigen 
delivery systems have been extensively investigated for decades, especially those based on hydrophilic polymers, 
such as alginate and chitosan, which have excellent biocompatibility, non-toxicity and biodegradability. 
The aim of this study was to prepare and characterize alginate microspheres as an antigen delivery system 
for immunization against leptospirosis. Alginate microspheres containing Leptospiral antigen (LA) were 
prepared by an emulsifi cation method and characterized for shape, size distribution, loading effi ciency (LE), 
loading capacity (LC) and release profi le. The effects of some parameters (such as concentration of alginate 
and emulsifi ers and stirring rate) on microspheres characteristics were investigated. The optimal condition 
parameters for the preparation of LA loaded alginate microspheres were estimated. The optimum concentrations 
were obtained for alginate and emulsifi ers, 3.5 % (w/v), span 80 (0.2 % w/v) and tween 80 (3.75 % w/v), 
respectively. Moreover, appropriate homogenizing rate was obtained at 500 rpm. Our results showed the mean 
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particle size of the microspheres as 200 μm, loading effi ciency 97 % and loading capacity 8 %. A suitable release 
profi le was observed for in vitro release test of LA from alginate microspheres over an extended period of time 
(192 hours). These results make the alginate microspheres particularly interesting for an LA delivery system. 
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Introduction 
Leptospirosis is a serious worldwide zoonosis caused by pathogenic Leptospira spp, 
and has also been identifi ed as a re-emerging infectious disease, particularly in tropical and 
subtropical regions (YAN et al., 2009). Transmission to humans occurs via contaminated 
water or soils, through the urine of infected animals. Moreover, the overall disease burden 
is underestimated, since l eptospirosis is a signifi cant cause of undifferentiated fever and 
is frequently not recognized. Barriers to addressing this problem have been the lack of 
adequate diagnostic tests and effective control measures. The presently available vaccines 
impart only short-term immunity, mediated by opsonizing antibodies, and fail to provide 
cross-protection against the large number of pathogenic serovars (ANDRE-FONTAINE 
et al., 2003). Although cell-mediated immunity is mostly directed against intracellular 
pathogens, several studies have demonstrated that protective immunity against Leptospira 
is correlated with Th1 responses, characterized by CD4+ and γδ T cell production of IFN- 
γ (KLIMPEL et al., 2003). An ideal vaccine against leptospira infection would therefore 
activate both humoral and cell-mediated immune responses ( FAISAL et al., 2009a). 
Although a number of potent adjuvants are available, adverse reactions due to toxicity 
have limited their use in vaccine formulations. Aluminum hydroxide (Alum) is the only 
adjuvant approved for human use but primarily induces humoral immune responses and 
only limited cell-mediated immunity. In addition, Alum is not effective for induction of 
mucosal immunity and can cause allergic reactions in some cases (GUPTA, 1998). The 
particulate antigen delivery systems (such as microspheres, liposomes, virosomes, etc.) 
are very potent adjuvants and have been widely used against variou s infectious diseases 
(BEHBOUDI et al., 1995). 
Microencapsulation is a process in which the cells are retained within an encapsulating 
matrix or membrane. Microencapsulation of antigens has been investigated for improving 
their immunogenicity. This process provides a long-term depot for the antigen and leads 
to inducing effective and long lasting immunity ( K RASAEKOOPT et al., 2004). 
Several particulate antigens, containing live or dead microorganisms have been proved 
to be effective immunogens, by using biodegradable polymers such as poly (lactic-co-
glycolic acid) (P LGA), poly-L-Lactid (PLLA) and alginate (FLICK-SMITH et al., 2002; YEH 
et al., 2002; FLORINDO et al., 2008). Immunization studies against leptospirosis via PLGA 
microspheres and liposomes have revealed that these particles are promising adjuvants 
for use with vaccines against leptospirosis ( FAISAL et al., 2009a,b). The most widely used 
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encapsulating material is alginate, a linear heteropolysaccharide of D-mannuronic and 
L-guluronic acid, which is extracted from various species of algae (KRASAEKOOPT 
et al., 2004). Recently, alginate m icrospheres have been used in various i mmunization 
studies (DOBAKHTI et al., 2006; TAFAGHODI et al., 2007; ARENAS-GAMBOA et al., 2008). 
There are hardly any data about the use of alginate microspheres as an adjuvant for use 
with vaccines against leptospirosis. Therefore in the present study, we investigated the 
optimum conditions for the preparation of alginate microspheres containing leptospiral 
antigens as a delivery system for immunization against leptospirosis.
Materials and methods 
Materials. Low viscosity sodium alginate (Sigma Chemical Co., USA), calcium 
chloride, Span 80, Tween80 and iso-octane (Merck, Germany) were employed for particle 
preparation. All other reagents used were of at least analytical grade.
Leptospira culture and preparation of antigen. Leptospira interrogans serovars 
Grippotyphosa (RTCC 2808), Sejroe hardjo (RTCC 2821) and Canicola (RTCC 
2805) were obtained from the Leptospira Reference Laboratory, Razi Vaccine and 
Serum Research Institute, Karj, Iran. The bacteria were inoculated into Ellinghausen- 
McCullough-Johnson-Harris (EMJH) medium (Difco Laboratories) at 28° C, for 7-10 
days. Bacterial growth was m onitored using d ark-fi eld microscopy. The bacteria were 
centrifuged at 17000 rpm for 20 min and the cell pellets were resuspended in phosphate 
buffered saline (PBS, pH 7.2), the cells were inactivated by formalin 0.5 % (v/v) and the 
viability of bacteria were checked and then they were stored at 4 ºC for 24 h. The cell 
suspensions contained 10 to 20 mg of cells (in terms of dry weight) per milliliter.
Preparation of particles. A lginate microspheres co ntaining leptospiral antigen 
(LA) were prepared by the modifi ed emulsifi cation method (J IN et al., 2009). Briefl y, 
LA was suspended in 10 mL 2-5 % (w/v) alginate solution and mixed with 20 mL iso-
octane containing 0.2-2 % (w/v) Span 80. The mixture was emulsifi ed for 3 min in a 
homogenizer (Heidolph, Germany) at 500-1000 rpm, followed by the addition of 1.5 
mL 3.75-30 % (w/v) tween 80 aqueous solution as the second emulsifi er, to achieve a 
suitable hydrophilic-lipophilic balance (HLB) value, and the mixture was further stirred 
at the same speed for 3 min. Then, 8 mL 8 % (w/v) calcium chloride solution was added 
dropwise. This cross-linking process lasted for 3 min. After the mixture was stirred for 
another 3 min, the alginate microspheres were collected by centrifugation, washed twice 
wit h deionized water and then the microspheres were suspended in 20 mL of poly-L-
lysine 0.1 % w/w. After 10 min homogenization, the alginate microspheres collected 
by centrifugation and then washed with deionized water and fi nally dried in a vacuum 
desiccator.
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Particle characterization. The morphology of LA  loaded microspheres was observed 
using optical microscopy (BX51, Olympus Corporation, Japan). The detailed morphology 
of the se microspheres was studied by scanning electron microscopy (SEM) (Oxford, UK). 
Microspheres for SEM were mounted on metal stubs previously covered with double- 
side adhesive, and coated with gold in vacuum conditions. Particle size (volume mean 
diameter) and size distribution of the microspheres were determined using a particle size 
analyzer (Malvern, UK).
Loa ding effi ciency (LE) and loa ding capacity (LC) of LA in alginate microspheres. 
The LE was calculated as the ratio between the mass of encapsulated agent in the 
recovered particles and the total mass of bacteria added during particle production. The 
LC was estimated as the ratio between the mass of the encapsulated agent in the recovered 
particles and the total mass of microspheres during particle production (JIN et al., 2009). 
After dissolving 80 g of dry particles with 5 mL of 0.75 M sodium citrate aqueous solution, 
overnight (LEM OINE et al., 1998), the samples were centrifuged at 10,000 rpm for 10 min 
and supernatant was neutralized by 0.1 M sodium hydroxide. Sample absorbance was 
determined at 585 nm and compared to a previously prepared standard curve. For each 
batch of microspheres the LE and LC were determined in triplicate.
In vitro antigenicity of LA . A critical point in developing a carrier system for antigens 
is the preservation of their native antigenicity. During alginate microsphere preparation, 
LA was exposed to potentially harsh conditions, such as contact with surfactants and 
organic solvents. This may result in alteration of the structural stability and decrease of 
ant igenicity of the antigen. Therefore, the in vitro antigenicity of LA was measured by 
enzyme-linked immunosorbent assay (ELISA) (FAISAL et al., 2009a). Each sample was 
examined at different dilutions against a linear scale showing the responses of control 
standard samples with different dilutions. The in vitro antigenicity of LA was evaluated 
by the ratio of ELISA response and protein concentration (ELISA/protein). 
In  vitro release studies. The in vitro release studies of alginate microspheres containing 
LA were carried out in PBS (pH 7.2). Accurately weighed amounts of LA  loaded alginate 
microspheres were put into eppendorf tubes (about 20 tubes) so that each tube contained 
1 mg of the microspheres and 1 mLof PBS. The eppendorf tubes were then incubated at 
37 °C under continuous shaking for 1 week. At various time intervals, the supernatant 
(250 μL) was drawn after centrifugation (13000 rpm for 10 min) and replaced with fresh 
medium. The LA released into the supernatant was quantifi ed by Bradford protein assay 
method. The in vitro release studies were performed in triplicates.
Results 
The effects of emulsion preparation conditions on particle characteristics. The 
infl uence of the preparation conditions, such as the concentration of alginate solution, 
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the concentration of emulsifi ers and the homogenizing rate, on the characteristics of 
the microspheres are shown in Tab les 1-3. The results showed that the most infl uential 
parameter for the characteristics of the microspheres was the homogenizing rate, followed 
by the concentration of alginate solution and the concentration of emulsifi ers in turn. The 
optimal parameters of the process were as follows: the concentrations of alginate solution 
and emulsifi ers were 3.5 % (w/v), span 80 (0.2 % w/v) and tween 80 (3.75 % w/v), 
respectively and the homogenizing rate was 500 rpm (Tables 1-3).





1.5 152 ± 2 Ag 
2.5 221 ± 1.73 Ag
3.5 272 ± 2.08 P
5 401.6 ± 2.88 D
Ag: aggregation, P: proper microsphere, D: deformed microsphere








 and particle size
0.1 2 229.66 ± 2.51 NS and P
0.2 3.75 272 ± 1.75 S and P
0.5 15 284.65 ± 3.51 S and IMP
1 30 300 ± 2.21 S and IMP
NS: non-stable  emulsion,  S: stable emulsion, P: proper microsphere, IMP: improper microsphere







500 274 ± 1.53 S and P
700 252.66 ± 2.07 S and IMP
1000 242 ± 2.64 S and IMP
S: stable emulsion, P: proper microsphere, IMP: improper microsphere
Mor phology, size and particle size distribution. The obtained alg inate mic rospheres 
and LA loaded alginate microspheres were characterized by SEM and a particle size 
analyzer. Two typical scanning electron microphotographs of bla nk microspheres and 
LA loaded microspheres are presented in Fig. 1. According to the fi g ure, the alginate 
microspheres were almost sph erical (Fi g. 1A), and alg inate microspheres containing 
LA were spherical without any aggregations (Fig. 1B). The average size of the alginate 
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microspheres was about 189 μm and the mean size of LA loaded alginate microspheres 
was about 200 μm, which was larger than the blank microspheres. The size distribution of 
alginate microspheres and LA  loaded alginate microspheres are presented in Fig. 2, which 
indicates that well dispersed alginate microspheres were prepared. 
 
Fig. 1. SEM images of alginate microspheres before loading (A) and after loading with antigen (B)
Fig. 2. Size distribution profi le of alginate microspheres before loading (A) and after loading with 
antigen (B)
LE and LC of LA in alg inate mi c rospheres. To assess the ability of the alginate 
microspheres to incorporate the inactive bacteria, the effects of the initial LA content on 
LE and LC were evaluated. Fig. 3 shows the effect of LA  concentration on the LE and LC 
of alginate mic rospheres. As shown in Fig. 3, on increasing LA  concentration, the LE and 
LC were increased. The LA with 20 mg/mL (1010 cell/mL) concentration led to maximum 
LE (97.41 %) and LC (8 %). The alginate microspheres with a concentration of 20 mg/
mL antigen were adapted to in vitro release.
A B













Particle size (m) Particle size (m)
A B
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 Fig. 3. Effects of different LA concentrations on loading effi ciency (A) and loading capacity (B) 
of sodium alginate microspheres
In vitro ant igenicity. The antigenicity of LA encapsulated in microspheres was 
evaluated by ELISA/protein ratio determination. Almost identical results were observed 
for the native LA and the LA released from the alginate microsphere (data not shown). 
There was no signifi cant antigenicity loss (10 % ± 2) induced by the encapsulation and 
subsequent release of LA from the alginate microspheres.
In vitro release. The in vitro release of LA from the alg inate microspheres was 
investigated in phosphate buffer solution (pH 7.2) at 37 °C. Slow release of LA from 
alginate microspheres occurred in the fi rst 8 h, subsequently rel ease was faster up to 48 h 
and over the next 192 h with an approximately constant rate, and about 64 % of LA were 
released in 5 days (Fig. 4). 
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Discussion 
Lep tospirosis, a zoonotic disease, has been recognized as an important emerging 
infectious disease over the last 10 years. Prevention of leptospirosis without vaccination 
is impractical and diffi cult to achieve. Currently available vaccines consist of killed 
whole cell bacterins, which are used widely in animals, but less so in humans (ADLER 
and MOCTEZUMA, 2009). Existing licensed vaccines have several drawbacks, including 
requiring multiple doses to induce protective effi cacy, and repeated annual revaccination 
to retain immunity. Therefore, safe and effi cacious immunization systems are needed to 
overcome these disadvantages. Hydrophilic microspheres have received much attention 
for delivery of therapeutic peptide, protein and antigen by intravenous, oral, and mucosal 
administration. Alginate has been widely used in pharmaceutical research as a carrier for 
drug and antigen delivery. 
Faisal et al. showed that the variable region of recombinant Leptospira 
immunoglobulin like protein A (LigAvar), incorporated into conventional liposomes 
and PLGA microspheres, produced robust immune responses that induced signifi cant 
protection against virulent L. interrogans serovar Pomona challenge in hamsters (FAISAL 
et al., 2009a). This group, in another study, prepared novel liposomes from total polar 
lipids of non-pathogenic Leptospira bifl exa serovar Patoc (designated leptosomes) and 
evaluated their vaccine adjuvant potential with novel protective antigens (Lp0607, 
Lp1118 and Lp1454) of L. interrogans serovar Pomona in a hamster model. Their results 
demonstrated that leptosome is a better adjuvant than conventional liposomes, as revealed 
by enhanced long term antibody response, lymphocyte proliferation and signifi cant 
enhancement of both Th1 (IFN-γ) and Th2 (IL-4 and IL-10) cytokines (FAISAL et al., 
2009b). 
In the present study we tried for the fi rst time to produce biodegradable alginate 
microspheres for loading leptospiral antigens, and to evaluate their potential as delivery 
systems. 
The results obtained from the study indicated that use of sodium alginate with 
concentrations lower than 3.5 % w/v led to the formation of low mechanical resistance 
mic rospheres due to diluting the polymeric solution. Such microspheres were small in 
size but during the production or drying procedure, due to high external energy, indicated 
coalescence and aggregation. In contrast, the samples with concentrations higher than 
3.5 % w/v sodium alginate were mostly deformed in shape and large in size. The 
probable reason was the high viscosity of the polymeric solution. Thereby, stirrer could 
not homogenize the viscose aqueous phase in the organic phase and produced deformed 
microspheres. These results were in accordance with previous reports (LE MOINE et al., 
1998; RODRIGUES et al., 2006; TAF AGHODI et al., 2006) but they are contrary to results 
reported by CHO et al. (1998). Of course it may be mentioned that the high homogenizing 
rate used by them may have caused the adverse results in comparison with other groups.
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Our study revealed that appropriate microspheres were fabricated with 0.2 % w/v 
span 80 and 3.75 % w/v tween 80. Similar to results reported by others (WAN et al., 1994; 
ZHENG et al., 2004; J IN et al., 2009), in lower concentrations of emulsifi ers the obtained 
emulsion was not stable and in higher concentrations of emulsifi ers the size of the 
microspheres decreased too much as a result of the reduction of the surface tension of the 
dispersed phase droplets. 
Whereas one of the most infl uential parameters for the characteristics of the 
microspheres was the hom ogenizing rate, the use of a suitable stirring rate may be 
signifi cant. On the basis of on evaluations in this study, stable and proper microspheres 
were made with a higher stirring rate (500 rpm), similar to results previously reported by 
other researchers (CHO et al., 1998; RODRIGUES et al., 2006). 
The effects of LA concentration on LE and LC were investigated and our results 
showed that by increasing the LA concentration, the LE and LC were increased. The 
LA at a 20 mg/mLconcentration led to maximum and considerable LE (97.41 %) and 
LC (8 %). Our results were similar to the majority of other experiences with alginate 
microspheres (WAN et al., 1992; KIM et al., 2002; S ANGEETHA et al., 2007). 
In the current study, to estimate the particle size distribution and mean diameter of 
the alginate mic rospheres, normal particle size distributions before and aft er loading 
with LA were determined. The mean diameter of microspheres after loading with LA 
was increased. The enhancement of the microspheres’ diameter may be caused by 
electrostatic bonds between polymeric chains and antigen proteinic chains on the surface 
of the microspheres. SEM photographs of LA loaded microspheres showed that alginate 
microspheres were almost spherical without any aggregation, as also reported by other 
studies (TAFAGHODI et al., 2006; JIN et al., 2009).
A lginate matrixes have been proven to be useful for the slow release of several 
potential therapeutic proteins, and several studies have demonstrated the usefulness of 
these systems (TAFAGHODI et al., 2007). Similarly in our study, the in vitro release profi le 
of LA loaded microspheres showed the long release time and slow release rate of LA 
result from the fact that LA macromolecules were bound to the microspheres by strong 
interaction. Additionally, after augmentation of poly-L-lysine, the electrostatic interaction 
between the positively charged -NH3+ of poly-L-lysine and negatively charged -COO- 
of alginate redounded to increase the stability of the microspheres. The presence of poly 
-L-lysine layer could reduce the diffusion of LA from the microspheres and prolong the 
release time of the LA. Subsequently, due to degradation and erosion of the matrix, the 
LA might be released from the alginate microspheres in an extended profi le. The results 
obtained by the present study were confi rmed by LEMOINE et al. 1998, and ANAL et al. 
2003.
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Conclusion
The properties of prepared microspheres containing leptospiral antigens were strongly 
dependent on both sodium alginate and emulsifi er concentrations, and the stirring rate 
of the emulsion was a critical factor for the preparation of suitable microspheres. The 
optimum concentrations of alginate and emulsifi ers led to the formation of the desirable 
microspheres and consequently high loading effi ciency, loading capacity and sustain 
release profi le. Therefore it is suggested that the alginate microspheres containing 
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SAŽETAK
Leptospiroza je zoonoza prouzročena patogenim vrstama roda Leptospira, a proširena je diljem svijeta. 
Iako današnja cjepiva protiv leptospiroze, proizvedena od cijelih bakterijskih stanica, mogu pružiti zaštitu od 
leptospiroze, potrebna su daljnja istraživanja nove generacije cjepiva koja će moći potaknuti tvorbu dugotrajne 
imunosti. Biološki razgradive mikrokuglice istražuju se desecima godina kao mogućnost sporog otpuštanja 
antigena, a posebice su zanimljive one od hidrofi lnih polimera kao što je alginat i kitosan, koji imaju izvrsnu 
biološku kompatibilnost, nisu toksični, a biološki su razgradivi. Svrha ovog rada bila je pripraviti alginatne 
mikrokuglice i odrediti njihova svojstva pogodna za otpuštanje antigena u postupku imunizacije protiv 
leptospiroze. Alginatne mikrokuglice s antigenom leptospira bile su pripravljene postupkom emulgacije te im 
je bio određen oblik, opseg distribucije, učinkovitost ugradnje antigena u mikrokuglice, kapacitet ugradnje i 
profi l otpuštanja antigena. Istraženi su učinci nekih pokazatelja (kao što je koncentracija alginata i emulgatora te 
omjer miješanja) na obilježja mikrokuglica. Procijenjeni su optimalni uvjeti za pripravu alginatnih mikrokuglica 
na koje je vezan antigen leptospira. Optimalna koncentracija za alginat bila je 3,5 % (w/v), a emulgator span 
80 (0,2 % w/v) i tween 80 (3,75 % w/v). Odgovarajuća homogenizacija postignuta je na 500 okretaja. Rezultati 
su pokazali da je srednja veličina mikrokuglica bila 200 μm, učinkovitost ugradnje antigena 97 %, a kapacitet 
8 %. In vitro je ustanovljeno da se antigen leptospira oslobađao s alginatnih mikrokuglica tijekom 192 sata. Ti 
rezultati pokazuju da alginatne kuglice mogu biti od posebnog interesa za oslobađanje antigena leptospira u 
organizmu.
Ključne riječi: Leptospira spp., antigen, alginat, mikrokuglice, otpuštanje antigena, imunizacija ________________________________________________________________________________________
